152
Views
6
CrossRef citations to date
0
Altmetric
Case Report

Secondary C-kit mutation is a cause of acquired resistance to imatinib in gastrointestinal stromal tumor

, , , &
Pages 760-763 | Received 12 Nov 2008, Published online: 08 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Jian-Hong Zhong, Liang Ma, Le-Qun Li, Hai-Ming Ru & Yin-Nong Zhao. (2011) Adjuvant imatinib for gastrointestinal stromal tumors: the current situation and problems. Scandinavian Journal of Gastroenterology 46:6, pages 645-651.
Read now

Articles from other publishers (5)

Newton A.C.S. Wong, Christel Garcia-Petit, Adam Dangoor & Nicola Andrew. (2022) A literature review and database of how the primary KIT/PDGFRA variant of a gastrointestinal stromal tumour predicts for sensitivity to imatinib. Cancer Genetics 268-269, pages 46-54.
Crossref
Elizabeta Popa, Felice Schnoll‐Sussman, Arun Jesudian, Govind Nandakumar & Manish A. Shah. 2017. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer 395 415 .
Liang Zong & Ping Chen. (2014) Prognostic value of KIT/PDGFRA mutations in gastrointestinal stromal tumors: a meta-analysis. World Journal of Surgical Oncology 12:1, pages 71.
Crossref
Elizabeta Popa, Felice Schnoll‐Sussman, Arun Jesudian, Govind Nandakumar & Manish A. Shah. 2012. Textbook of Uncommon Cancer. Textbook of Uncommon Cancer 389 408 .
Mario Díaz Delgado, Alicia Hernández Amate, María Sánchez León, Sofía Pereira Gallardo & Ricardo González-Cámpora. (2010) Avances en los tumores del estroma gastrointestinal. Revista Española de Patología 43:1, pages 16-23.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.